Doctors’ knowledge, attitudes, and compliance with 2013 ACC/AHA guidelines for prevention of atherosclerotic cardiovascular disease in Singapore

References

• World Health OrganizationCardiovascular Diseases (CVDs), fact sheet updated January 2015 Available from: http://www.who.int/mediacentre/factsheets/fs317/en/Accessed March 16, 2015
   Google Scholar
• World Health OrganizationGlobal Status Report on Noncommunicable Diseases 2014 Available from: http://www.who.int/entity/nmh/publications/ncd-status-report-2014/en/index.htmlAccessed March 16, 2015
   Google Scholar
• OhiraTIsoHCardiovascular disease epidemiology in Asia – an overviewCirc J2013771646165223803294
   PubMed Web of Science ®Google Scholar
• The Registry of Births and Deaths, Immigration and Checkpoints AuthorityReport on Registration of Births and Deaths 2013SingaporeThe Registry of Births and Deaths, Immigration and Checkpoints Authority Available from: http://www.ica.gov.sg/data/resources/docs/Media%20Releases/SDB/Annual%20RBD%20Report_2013.pdfAccessed December 22, 2014
   Google Scholar
• Ministry of HealthDisease BurdenSingaporeMinistry of Health2012 Available from: https://www.moh.gov.sg/content/moh_web/home/statistics/Health_Facts_Singapore/Disease_Burden.htmlAccessed December 22, 2014
   Google Scholar
• YoonKHLeeJHKimJWEpidemic obesity and type 2 diabetes in AsiaLancet200636895481681168817098087
   PubMed Web of Science ®Google Scholar
• SmithDGEpidemiology of dyslipidemia and economic burden on the healthcare systemAm J Manag Care2007133S68S7117596114
   PubMed Web of Science ®Google Scholar
• StamlerJDaviglusMLGarsideDBDyerARGreenlandPNeatonJDRelationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevityJAMA2000284331131810891962
   PubMed Web of Science ®Google Scholar
• Epidemiology and Disease Control Division, Ministry of HealthNational Health Survey2010SingaporeEpidemiology and Disease Control Division, Ministry of Health, Singapore Available from: https://www.moh.gov.sg/content/dam/moh_web/Publications/Reports/2011/NHS2010%20-%20low%20res.pdfAccessed March 16, 2015
   Google Scholar
• YusufSHawkenSOunpuuSEffect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTER-HEART study): case-control studyLancet2004364943893795215364185
   PubMed Web of Science ®Google Scholar
• De CaterinaRZampolliADel TurcoSMadonnaRMassaroMNutritional mechanisms that influence cardiovascular diseaseAm J Clin Nutr2006832S421S426
   PubMed Web of Science ®Google Scholar
• TalwalkarPGSreenivasCGGulatiABaxiHJourney in guidelines for lipid management: From adult treatment panel (ATP)-I to ATP-III and what to expect in ATP-IVIndian J Endocrinol Metab201317462863523961478
   PubMedGoogle Scholar
• GrundySMCleemanJIMerzCNImplications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelinesCirculation2004110222723915249516
   PubMed Web of Science ®Google Scholar
• WatersDDBrotonsCChiangCWLipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goalsCirculation20091201283419546386
   PubMed Web of Science ®Google Scholar
• KimHSWuYLinSJCurrent status of cholesterol goal attainment after statin therapy among patients with hypercholesterolemia in Asian countries and region: the Return on Expenditure Achieved for Lipid Therapy in Asia (REALITY-Asia) studyCurr Med Res Opin20082471951196318547466
   PubMed Web of Science ®Google Scholar
• Ministry of HealthClinical Practice Guidelines: LipidSingaporeMinistry of Health2006 Available from: https://www.moh.gov.sg/content/moh_web/home/Publications/guidelines/withdrawn_cpgs.htmlAccessed December 22, 2014
   Google Scholar
• StoneNJRobinsonJGLichtensteinAH2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice GuidelinesJ Am Coll Cardiol20146325 Pt B2889293424239923
   PubMed Web of Science ®Google Scholar
• JohnsonKMDoweDAAccuracy of statin assignment using the 2013 AHA/ACC Cholesterol Guideline versus the 2001 NCEP ATP III guideline: correlation with atherosclerotic plaque imagingJ Am Coll Cardiol201464991091925169177
   PubMed Web of Science ®Google Scholar
• LuvaiAMbagayaWHallASBarthJHRosuvastatin: a review of the pharmacology and clinical effectiveness in cardiovascular diseaseClin Med Insights Cardiol20126173322442638
   PubMedGoogle Scholar
• ArcaMGaspardoneAAtorvastatin efficacy in the primary and secondary prevention of cardiovascular eventsDrugs200767Suppl 1294217910519
   PubMedGoogle Scholar
• National Institute for Health and Care ExcellenceLipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and cardiovascular diseaseNICE clinical guideline 1812014 Available from: http://www.nice.org.uk/guidance/cg181Accessed December 22, 2014
   Google Scholar
• American Diabetes AssociationCardiovascular disease and risk management. Sec 8. In Standards of Medical Care in Diabetes – 2015Diabetes Care201538Suppl 1S49S5725537708
   PubMedGoogle Scholar
• LeeERyanSBirminghamBRosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environmentClin Pharmacol Ther200578433034116198652
   PubMed Web of Science ®Google Scholar
• GandelmanKFungGLMessigMLaskeyRSystemic exposure to atorvastatin between Asian and Caucasian subjects: a combined analysis of 22 studiesAm J Ther201219316417320975528
   PubMed Web of Science ®Google Scholar
• JonesPHMcKenneyJMKaralisDGDowneyJComparison of the efficacy and safety of atorvastatin initiated at different starting doses in patients with dyslipidemiaAm Heart J20051491e115660024
   PubMed Web of Science ®Google Scholar
• PaneloAAFernandoRESyRGThe efficacy and safety of atorvastatin 10, 20, 40 and 80 mg in Filipino dyslipidemic patients: the lipitor dose-response study in Filipinos [abstract]Philipp J Intern Med2005435293300 Available from: http://pimedicus.upm.edu.ph/index.php?fetch_detailed=5233&KeyWords=&Media=&Heading=&Operator=&offset=&total=&limit=&marcAccessed December 24, 2014
   Google Scholar
• HuMCheungBMTomlinsonBSafety of statins: an updateTher Adv Drug Saf20123313314425083232
   PubMedGoogle Scholar
• KellerDMPLANET I and II: Atorvastatin beats rosuvastatin for protecting kidneys in diabetic and nondiabetic patientsMedscape7052010 Available from: http://www.medscape.com/viewarticle/790656Accessed December 22, 2014
   Google Scholar
• De ZeeuwDAnzaloneDACainVARenal effects of atorvastatin and rosuvastatin in patients with diabetes who have progressive renal disease (PLANET I): a randomised clinical trialLancet Diabetes Endocrinol20153318119025660356
   PubMed Web of Science ®Google Scholar
• CampeseVMStatins and the kidney: friend or foe?Lancet Diabetes Endocrinol20153316116225660357
   PubMed Web of Science ®Google Scholar